Radiation Therapy Prostate Cancer VMAT IMRT

According to a study in the January issue of the Journal of the American College of Radiology, the use of volume-modulated arc therapy (VMAT) to deliver intensity-modulated radiation therapy (IMRT) to prostate cancer patients results in an overall reduction in treatment time of approximately 14 percent.

Neusoft Corporation announced that it has signed a Term Sheet with Philips on the proposed transaction of shares and assets in Philips and Neusoft Medical Systems Co. Ltd. ("PNMS"). According to the Term Sheet, Neusoft's wholly owned subsidiary Neusoft Medical System Co. Ltd. and its overseas associates intend to acquire 51 percent equities in PNMS held by Philips. Upon the completion of the proposed transaction, all intellectual property rights of PNMS will be shared by both Neusoft and Philips. In addition, a team of approximately 100 to 150 computed tomography (CT) system and component engineers and supporting staff will transfer from the joint venture to Philips.

Montage Healthcare Solutions and Mammography Reporting Systems (MRS) have announced a partnership that will provide Montage's analytics tool to MRS customers, as well as enable MRS to resell the Montage Search and Analytics solution.

Cloud computing has the potential to revolutionize healthcare administration by allowing providers to access information from a patient’s medical file at anytime from anywhere, and that means patients receive better and more efficient quality care.
Radiology Test Results Primary Care Physicians Clinical Study

According to a study in the February issue of the Journal of the American College of Radiology, primary care physicians prefer to deliver the results of radiology examinations themselves and feel medico-legally obligated by recommendations within radiology reports.   
Accuray Inc. European CyberKnife Center Munich-Grosshadern CyberKnife M6 System

Accuray Inc. announced that the European CyberKnife Center Munich-Grosshadern (ECZM) has treated the world’s first patient with the new CyberKnife M6 System. With the installation of the new system, the Munich center, in close cooperation with the University Hospital of Munich, is the first to offer cancer patients treatment with the CyberKnife M6 System, the latest generation of the CyberKnife System. The new system is now able to provide enhanced quality, a streamlined user interface for treatment delivery and precision to radiation therapy treatments and continues to provide clinical capabilities including non-isocentric, non-coplanar robotic beam delivery and real-time tracking and automatic correction.

While amyloid imaging may now be most associated with detecting plaques in the brain, it has the potential to change the way cardiac amyloidosis is diagnosed. According to first-of-its-kind research published in the February issue of The Journal of Nuclear Medicine, positron emission tomography (PET) with 11-C PIB can positively visualize amyloid deposits in the heart. Currently there is no noninvasive test available for specific diagnosis.

Identive Group Inc. announced new radio frequency identification (RFID) labels for the medical industry that are specially designed to withstand the radiation processes commonly used to sterilize medical devices, equipment and supplies. Unlike standard RFID products that lose their memory content when exposed to radiation, Identive's new radiation-resistant labels enable critical identification, usage and tracking information to reside on medical components and storage containers throughout their useful lives.

 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now